Pricing Log in Create free account

Calidi Biotherapeutics, Inc. (CLDI) vs GRI Bio, Inc. (GRI)

Calidi Biotherapeutics, Inc. and GRI Bio, Inc. are both Biotechnology companies. Calidi Biotherapeutics, Inc. and GRI Bio, Inc. are of similar size ($3.2M and $3.1M). Calidi Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. Across the 10 metrics below, GRI Bio, Inc. leads on 8 and Calidi Biotherapeutics, Inc. on 2.

Valuation

Metric CLDI GRI Biotechnology median
P/E n/m 0.02 8.50
P/S n/m n/m 9.71
P/B 0.38 0.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 0.86 0.64
EV/Sales n/m n/m 9.21
Earnings yield (6,464.29%) 5,408.03% (33.15%)
Free cash flow yield (1,500.29%) (418.56%) (25.50%)

Profitability

Metric CLDI GRI Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (900.56%) (142.02%) (56.36%)
Return on assets (283.36%) (113.27%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDI GRI Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 83.31% 92.12% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI GRI Biotechnology median
Debt to equity 0.24 0.00 0.00
Current ratio 1.68 10.30 4.72
Net debt to EBITDA 0.26 0.69 0.96

Dividend

Metric CLDI GRI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLDI GRI Biotechnology median
Market cap 3.20m 3.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack